Habtoor Leighton JV wins $316m Saudi hospital deal
JV for King Fahad Medical City scheme to take three years to complete
Habtoor Leighton Group (HLG) has been awarded a healthcare project worth $316m by the Ministry of Health King Fahad Medical City.
The project, referred to as PPNNCC, will see a series of new medical centres built on the site of the current King Fahad Medical City campus in central Riyadh. It will be delivered through a joint venture partnership with Al Latifia Trading and Contracting.
Facilities being built include: a new 11-storey National Neurosciences Institute; an 11-storey cancer treatment centre; a three-storey cardiac centre; a seven-storey block containing laboratories and offices, and two levels of ground floor parking.
There will also be a four-storey central services buildings and a proton lab set to be delivered under a new central services contract.
HLG's outgoing CEO Laurie Voyer said the new project vindicated the firm's strategy of increasing its geographic spread.
“Saudi Arabia is our largest growth market, and this project underlines our ability to secure work there,” he said.
The company's managing director-elect, Jose Antonio Lopez-Monis, said the medical project, which will be the first of five specialist hospitals to be built in Saudi Arabia over the next five years, will see it deliver modern healthcare facilities.
“We have developed a strong track-record in delivering state-of-the-art healthcare projects, with Mafraq Hospital and Arzanah Wellness & Diagnostic Center, both located in Abu Dhabi - leading examples of our specialist skills and technical expertise in this growing sector,” he said.
The project, which will add 510 new hospital beds to th King Fahad Medical City complex, will begin on site later this year and take three years to complete.